Subscribe to Newsletter
Subspecialties Cataract

A Brief History of IOL Materials

| Florian Kretz, Sibylle Scholtz, Gerd Auffarth

The development and use of intraocular lenses has been a major ophthalmic success story. Here, we describe some of the key contributions and the materials that revolutionized cataract treatment.

Subspecialties Professional Development

First Lady of the Gonin Medal

Sitting Down With Alice McPherson,founder of the Retina Research Foundation

Business & Profession Cornea / Ocular Surface

Beaming for Better Cross Linking

| David Geffen, Paul Karpecki

Increasing the light intensity over the thinnest point of the cornea – the periphery –improves outcomes of corneal collagen cross-linking in keratectasia patients.

Business & Profession Refractive

How to Reduce Higher-Order Aberrations

A new technology that measures subjective refraction based on point spread function targets generates better data, increases efficiency in the clinic and improves patient outcomes.

Subspecialties Professional Development

Serving Patients who have Learning Disabilities

| Rachel Pilling

People with learning disabilities are ten times more likely to have serious sight problems than the general population and often fail to receive the same standard of care. Here’s how to avoid some of the pitfalls and some tips for a successful doctor-patient relationship.

Business & Profession Other

The Uniqueness of Uveal Melanoma

| Takami Sato , Carol Shields

Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.

Subspecialties Cornea / Ocular Surface

Combatting Corneal Steepening

| Mark Hillen

A three-year study of progressive keratoconus has shown that corneal cross-linking is associated with sustained delay in disease progression.

Business & Profession Professional Development

Regrets, I’ve Had a Few…

| Mark Hillen

If you had your time again, would you go to medical school, and would you choose ophthalmology?

Business & Profession Other

Don’t Disrespect Diamox

| Mark Hillen

Around since the 1950s, it has now been proven to improve visual outcomes in patients with idiopathic intracranial hypertension

Business & Profession Professional Development

Valeant Stalks Allergan

| Mark Hillen

To shave $2.7 billion from costs there will be substantial cuts and job losses

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: